Practice Management

- A Network of Your Peers More Practice Management Videos >>

Carol Bush on Navigators and Healthcare Reform

Dr. Richard Silver Discusses the High Cost of Drugs in CML

The Cost-Effectiveness of Targeted Therapies in NSCLC

Dr. Deepak Kapoor on Integrated Urology Practices

Latest Practice Management Articles View more >>

Clinical Pathways: An Evolutionary Approach to Cancer Care

Clinical pathway programs are evolving as a primary means by which payers intend to control drug utilization in cancer treatment.

Oncology Business Management > Feature

Is Our Healthcare System Ready to Integrate Cancer Care?

In response to the billions of dollars wasted each year in the United States on fragmented, ineffective, and uncoordinated care, some healthcare reform efforts have focused on integrating the delivery of healthcare.

Oncology Business Management > Cover Story

Value-Based Purchasing: How Physicians Will Be Compensated in the Future

An interview with Frank G. Opelka, MD, exploring some of the health policy initiatives that will impact how physicians will be compensated in the future.

Urologists in Cancer Care > Feature Article

Surveillance Following Orchiectomy Most Costly Option for Stage I Testicular Seminoma

A cost analysis found that para-aortic radiotherapy, dogleg radiotherapy, and 1 cycle of carboplatin are cost-effective strategies for the management of stage I testicular seminoma post-orchiectomy compared with surveillance.

Urologists in Cancer Care > Conference Highlights

Focusing on Clinical and Economic Outcomes—Not Guidelines: Is It Time for a New Direction in Oncology Care?

Interview With Andrew Pecora, MD, President, Regional Cancer Care Associates, Chief Innovations Officer and Vice President, Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center, Editor-in-Chief, Oncology & Biotech News

Oncology & Biotech News > Reimbursement and Managed Care News

Evidence-Based Oncology View more >>

Bundled Payment: Practice Savior or Killer?

As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.

Value-Based Contracting for Pharmaceuticals: Getting Ready for Prime Time?

Applying Accountable Care to Oncology: Developing an Oncology ACO

The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.

Five Trends Emerge in Payer Management of Oncology

Market Dynamics Change How Plans Manage Oral and Office-Administered Agents

Measuring Quality Cancer Care

Searching for Clinical and Economic Value in Pancreatic Cancer

Performance Metrics in Oncology

Chemoprevention in Prostate Cancer: Identifying Patients at Greatest Risk May Provide Greatest Value

The Future of Melanoma Treatment

Literature Review: Chronic Myeloid Leukemia

Literature Review: Melanoma

Crossroads in Breast Cancer: The Intersection of Clinical Uncertainty and Molecular Profiling

ASH Conference Coverage

Managed Care Restrictions: Barriers to Product Use in Cancer Care